3rd Quarter - Report
NVG, LLC for BIOGEN
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Implementation of The Patient Protection Affordable Care Act (P.L. 111-148); biosimilar provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA GERMAN FOSTER | — |
| ANDREA LARUE New | — |
Copyright/Patent/Trademark CPT
Patent Reform Act of 2011 (P.L. 112-029).
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREA LARUE | — |
Budget/Appropriations BUD
The Budget Control Act of 2011 (P.L. 112-25)
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA GERMAN FOSTER | — |
| ANDREA LARUE New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.